Mark Duggan is an entrepreneur and executive with nearly 30 years of leadership experience at small biotechnology and biopharmaceutical companies. He is currently President and Founder of LifeSci Consulting LLC though which he provides technical and strategic guidance to academic institutions, research institutes, and biotech/biopharma companies on drug discovery and development initiatives. Before then, Mark was Vice President in the AstraZeneca Neuroscience iMed, playing a key role in building this “biotech-like” unit. Previously, Mark was Vice President of Scientific Operations at SciFluor Life Sciences where he helped shape the business plan and vision for the early-stage biotechnology company. Prior to SciFluor, Mark was Vice President of Chemistry and Preclinical Development and an executive team member at Link Medicine. Previously, Mark led the Medicinal Chemistry Department at Amgen, Cambridge and served as Site Head. Before Amgen, Mark spent 18 years at Merck Research Laboratories where he contributed to the strategic direction of drug discovery programs and successfully led programs in the areas of bone biology, endocrinology, oncology, and neuroscience, was a co-inventor of Aggrastat®. Mark has authored over 70 publications and is an inventor on over 70 issued US patents.